HomeOpen Access NewsAlzheimer's Disease

Alzheimer's Disease

Promising Alzheimer’s vaccine enters phase 1 clinical trial to target tau protein

University of New Mexico researchers are launching a phase 1 clinical trial of a novel Alzheimer’s vaccine designed to clear tau protein.

ArrestAD: Exploiting the bittersweet side of Alzheimer’s disease

The Alzheimer’s disease puzzle is being completed. This is where the ArrestAD programme comes in, to exploit the bittersweet side of AD.

Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s

Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.

A Bluetooth tracking device to aid the search for older people with dementia who get lost

Getting lost can affect caregivers and families of older people with dementia – now, a Bluetooth tracking device can assist the search for their loved ones.

Searching for a novel marker of preclinical Alzheimer’s disease

Research suggests that multisensory integration could be used as a novel marker for preclinical Alzheimer’s disease given reported associations between magnitude of visual-somatosensory integration and important cognitive and motor outcomes.

What we need to make breakthroughs in dementia research

David Thomas, Head of Policy (Access and Innovation) at Alzheimer’s Research UK, looks at what we need to make breakthroughs in dementia research.

Three rare brain diseases that attack your language skills

According to NorthWestern Medicine, there are three different brain diseases that attack the language areas in the left hemisphere of the brain.

Late-onset alcohol abuse can be symptom of dementia

According to new results in the Journal of Alzheimer’s Disease, patients who start abusing alcohol in later life – after age 40 – maybe doing so due to underlying dementia

The importance of dementia day care services during COVID-19

Professor Timothy Kwok, Director of the Jockey Club Centre for Positive Ageing, and Research Manager Ms Bel Wong, explain the necessity of dementia day care services during the pandemic.

Amyloid oligomer & membrane channel structures

H. Robert Guy, CEO from Amyloid Research Consultants, ascertains why amyloid oligomer & membrane channels structures can & must be determined.

Lowest global rates of dementia in Indigenous communities

The healthier pre-industrial lifestyles which Indigenous communities live by present solutions in preventing Alzheimer’s and dementia ­– as seen in their lower rates of the disease.

How to help someone living with dementia understand the COVID-19 pandemic

Kym Ward, Dementia Project Coordinator at The Brain Charity, offers insight into how to support those living with dementia during times of uncertainty and isolation.

What is the reason for cognitive decline in Alzheimer’s disease?

New tech has helped confirm that the destruction of brain synapses underlies the cognitive deficits experienced by patients with Alzheimer’s

What happens to our brains when we multitask?

The Del Monte Institute for Neuroscience have been shedding light on how health brains are able to multitask while walking

$2 million grant to explore link between chronic stress and Alzheimer’s

Researchers at WVA are investigating the connection between chronic stress and Alzheimer’s Disease using new $2 million grant from NIH

Protecting ageing synapses through exercise

Keeping the ageing population as active as possible, enhances the connections between neurons to maintain healthy cognition.

Alzheimer’s: A disease not just about memory loss

Head of Research Dr Sara Imarisio brings to light emerging research on the link between epilepsy and Alzheimer’s disease

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders